《Invest India：2023年印度生物技术手册（英文版）（52页）.pdf》由会员分享，可在线阅读，更多相关《Invest India：2023年印度生物技术手册（英文版）（52页）.pdf（52页珍藏版）》请在三个皮匠报告上搜索。

1、INDIA BIOTECHHANDBOOK 20231INDIA BIOTECHHANDBOOK 20232ImmuneelINDIA BIOTECHHANDBOOK 20233Foreword by ABLE President 04India Delegation#BIO2023 06Industry Co-leaders 09Program Schedule 14Overview of Indias BioEconomy 18India Pavilion Exhibitor Profiles 24India Pavilion Exhibitor Positioning 38Connect

2、 with Team India at BIO 2023 42India Exhibits at BIO Boston 2023 Locator 48Table of ContentsAcknowledgementsIndia Biotech Handbook has been envisioned and published by Narayanan Suresh,Chief Operating Officer,Association of Biotechnology Led Enterprises(ABLE).Designed and printed by Sareeta Sajjan.T

3、he editorial responsibility,content,and analysis was co-ordinated and carried out by Srinivas Rao Chandan,Senior Consultant to ABLE;Ms Pavana Praveen,Manager-BDO&Ms Indrila Sengupta,Asst.Manager-BDO.Dr Balasubramanya S.,General Manager is the Chief Coordinator for the INDIA PavilionBIO Boston,June 5

4、-8,2023.Comments and questions are welcome and should be addressed to:Narayanan Suresh,Chief Operating Officer,Email:cooableindia.org.in Website:www.ableindia.in ASSOCIATION OF BIOTECHNOLOGY LED ENTERPRISES(ABLE)No.123/C,16th Main Road 4th Block,5th Cross,Koramangala,Bangalore-560034,India.Tel.:+91-

5、80-41636853INDIA BIOTECHHANDBOOK 20234Indias$93 billion bioeconomy aims for increased self-relianceABLE was formed 20 years ago by a small group of biotech industry leaders as they felt the need to articulate many niggling issues related to regulatory provisions and lack of a coherent policy for the

6、 segment.This happened when they visualized more entrepre-neurs coming into the sector,providing by the wide range of products and services that can be developed using various biotechnological tools.I can say confidently that ABLE,as an organization,has not looked back since the first steps taken by

7、 the visionary founders.It was evident during the Covid-19 pandemic years when ABLE members delivered more than 2.3 billion doses of vaccines not just for our own people but to the entire world in a very short span of time.Literally start-ing from scratch,our member companies produced enough and mor

8、e testing kits for exports too.A wide range of anti-virals were produced to control the disease.Very few countries have showed such high levels of self-reliance in tackling the unexpected health disaster that swept the world for nearly three years from early 2020.Of course,our member companies are n

9、ot just relying on the past glory,they are pre-paring in every possible way to face the challenges of the future.They look to every available opportunity.As the world turns to alternate protein sources,Indian compa-nies are at the forefront of developing a host of these products and is now a preferr

10、ed destination for innovation,develop and manufacture the new age food products.As the world grapples with the problems induced by climate change,helped by innovative gov-ernment policies,ABLE members played a key role in developing technologies for the conversion of Biomass into fuel and succeeded

11、in the implementation of 10%blended ethanol in petrol.They will play even greater role as the nation sets up more bio refin-eries to produce enough biofuels to achieve the 20%blending target by 2025.Some of Indias key biotech companies and institutions are present BIO Boston 2023 to show case their

12、capabilities for the world to see and seek collaborations to replicate these in other parts of the world.This special publication,“India Biotech Handbook 2023”,is an attempt to showcase these players who are present in this prestigious event.I am sure you will find this publication useful as you pre

13、pare to engage with Indias$93 billion and growing BioEconomy that has over 600 established companies and 7,300+biotech startups.G S Krishnan,Hon.President-ABLEINDIA BIOTECHHANDBOOK 20235INDIA BIOTECHHANDBOOK 20236India Delegation at BIOCover pagePeople conceptINDIADelegation#BIO2023INDIA BIOTECHHAND

14、BOOK 20237Dr Rajesh S.Gokhale is the Secretary at Department of Biotechnology in the Ministry of Science&Technology,Government of India.He is presently on dep-utation from Indian Institute of Science Education&Research IISER Pune.Prior to this,he was at National Institute of Immunology NII and was a

15、lso Director of CSIR-Institute of Genomics and Integrative Biology CSIR-IGIB for seven-and-half years.During his tenure he established the South Campus of CSIR-IGIB,where he led interdis-ciplinary initiatives in translational genomics research programs focused in delineating a variety of complex dis

16、eases.Dr.Gokhale is trained as a chemical biologist from Indian Institute of Science IISc,Ban-galore and Stanford University,USA.His significant research contributions are in dis-covering novel metabolites and their pathways,which dictate pathophysiology of human diseases.Recent work from his labora

17、tory have identified two novel metabolites from infectious pathogen Mycobacterium tuberculosis,that are crucial for initiating complex infection process.His group have also significantly contributed to the understanding of autoimmune disease Vitiligo.Studies from his group has elucidated complex int

18、erplay between metabolic reprogramming and immune system,to develop novel therapeutic strategies that can tackle the underlying causes,rather than just the symptoms.Sci-entific work from his laboratory has been published in prestigious journals like Nature,Nature Chemical Biology,Molecular Cell,The

19、Proceedings of the National Academy of Sciences etc.He has mentored more than 200 students and about 25 students have completed PhD thesis from his group.Dr Gokhale co-founded Vyome Biosciences Pvt.Ltd.VYOME in 2010,a biopharmaceutical company developing best in class drugs for dermatology.This comp

20、any is presently completing Phase IIb clinical trial for drug-re-sistant acne and has launched OTC products in the market.Dr.Gokhale was a Wellcome Trust Senior Research Fellow,UK and an International HHMI Fellow,USA.He is recipi-ent of several awards,including Infosys Prize,Shanti Swarup Bhatnagar

21、Prize,National Bioscience Award,J C Bose National Fellowship and IIT Bombay Distinguished Alumni Award.He is also Fellow of all the three Indian National Science Academies.Dr Rajesh S GokhaleSecretary-Department of Biotech-nology(DBT),Ministry of Science&Technology,Government of IndiaChairman-Biotec

22、hnology Indus-try Research Assistance Council(BIRAC)INDIA BIOTECHHANDBOOK 20238Dr.Alka Sharma is currently Scientist H/Senior Adviser in the Department of Biotechnology DBT,Ministry of Science&Technology,Government of India.Dealing with research and policy issues in the emerging areas of biotechnolo

23、-gy,she has made significant contributions in med-tech innovation with national and international partnerships,early and late translational research on various domain specific areas of biotechnology such as vaccine research&development diagnostics,stem cells and regenerative medicine,biomedical engi

24、neering biodesign,setting up bioclusters across the country for innovation driven research,technology and product development.She has been instrumental in promoting and supporting public-private partnerships across the country and also in the commercialization of indigenous and affordable technologi

25、es for a large number of patients in urban and rural settings.Her efforts have resulted in the creation of several start-ups,the development of functional biomedical device prototypes,the transfer of technologies,and the creation of a pool of med-tech innovators in the country.Actively involved in f

26、ormulating various legislations in Biotech sector and heading the Biosafety Regulation Division including RCGM in DBT.She is the Coordinator for Man-agement of COVID-19 related activities in DBT/BIRAC and also contributing towards AtmaNirbhar Bharat through National Biotech Resource Indigenization C

27、onsortium(NBRIC).She is the Scientific Coordinator of four autonomous institutions of DBT and also coordinating for scientific activities of ICGEB.She is proactively promoting and supporting bilateral partnerships with various countries such as USA,Sweden,Finland,France and Australia.She has receive

28、d training at the Department of Microbiology and Infectious Diseases,NIH,USA for the management of extramural programmes.Also she has also received“CSIR Technology Award for Innovation”for her translational work.Dr Alka SharmaSenior Advisor-Department of Biotechnology(DBT),Ministry of Science&Techno

29、logy,Government of IndiaManaging Director-Biotechnology Industry Research Assistance Council(BIRAC)INDIA BIOTECHHANDBOOK 20239Dr.Sanjay MishraSenior AdvisorDepartment of Biotechnology(DBT),Ministry of Science&Technology,Govern-ment of IndiaDr.Manish DiwanGeneral Manager&Head,SPEDBiotechnology Indust

30、ry Research Assistance Council(BIRAC)Dr.PKS SarmaGeneral Manager&Head,Tech-nical,Biotechnology Industry Research Assistance Council(BIRAC)Dr.Amita JoshiChief Manager,TechnicalBiotechnology Industry Research Assistance Council(BIRAC)Dr.Aparna SharmaSenior Manager,TechnicalBiotechnology Industry Resea

31、rch Assistance Council(BIRAC)Dr.P M MuraliPresident,Council of Presidents,ABLE,CMD,JananomG S KrishnanPresident,ABLENarayanan SureshCOO,ABLEDr Balasubramanya SGeneral Manager,ABLEDr.Ramjee PallelaCOO,Atal Incubation Centre-Centre for Cellular and Molecular Biology(AIC-CCMB)Ritika MarampalliHead,Corp

32、orate Relations,Atal Incubation Centre-Centre for Cellular and Molecular Biology(AIC-CCMB)Paul V.ThomasGlobal Head,Portfolio Strategy&Program Management,Biocon Biologics LimitedSushanth BodaSenior Director-Strategy,BD&InnovationBiocon Biologics LimitedALN ReddyVice President,Biological E.LimitedDr.M

33、artin ReersExecutive Vice President,Biological E.LimitedDr.Selva Kumar NatesanCEO,DSK InnoSciences Private LimitedDr.Ananya JeshtadiVP-Global Business DevelopmentDSK InnoSciences Private LimitedDeepanwita ChattopadhyayChairman&CEO,IKP Knowledge ParkIndustry Co-LeadersINDIA BIOTECHHANDBOOK 202310Band

34、hana KatochPrincipal Advisor,IKP Knowledge ParkHarshada Shrikant WadkarSenior Manager,IKP Knowledge ParkDr.Tuhin BhowmickCofounder&CEO,Pandorum TechnologiesVishal GoelMD,Rx PropellantMilind RaviCEO,Rx PropellantDr.Ketki TulpuleVP-International Business Development&Strategy,Rx PropellantGaurav Kumar

35、RastogiVP-Business Development,Rx PropellantPoongumaran Panneer SelvamMD,TICEL Bio Park LimitedSenthilkumar VanarajanManager-(Scientific/Bioprocess)TICEL Bio Park LimitedDr.Chandrashekaran SiddamadappaMD,Chairman&FounderVipragen Biosciences Private LimitedYashas ChandrashekharCOO,Vipragen Bioscience

36、s Private LimitedDr.Narasimha Rao NedunriMD&CEO,Clonz Biotech Private LimitedMuralidhar Reddy MamillaCOO,Clonz Biotech Private LimitedVijay Babu GarlapalliVP-Production,Clonz Biotech Private LimitedAadya MalladiBusiness Development Executive,Embio Akash MurthyFounder,EuprimeMurthy Chavali(CSN)CEO,Sa

37、tya Pharma Innovations Private LimitedSrikanth KondaDirector,Sparity,Inc.Meghana AlluriClient Success Specialist,Sparity,Inc.BN ManoharMD&CEO,Stempeutics Research Private LimitedRippleben Bhavik MehtaInvestment AdvisorStempeutics Research Private LimitedWaman WaghMD,Adam Fabriwerk Pvt LtdAbishek Iye

38、rAssistant General ManagerAlembic Pharmaceuticals LimitedINDIA BIOTECHHANDBOOK 202311Manoj GopalkrishnanFounder&CEO,Algorithmic Biologics Pvt Ltd.Sandeep SinghMD,Alkem LabsHermes VoraDGM-International Business Development,Ami Polymer Pvt LtdRishi GanjuDirector-MarketingAtrimed Plant ScienceSubir Dub

39、eyVP-Business DevelopmentAurigene Oncology LimitedSujatha RajagopalanAssociate Director-Business Development,Aurigene Oncology LimitedAkshay ShuklaDirector,NBE Strategy&Business Devel-opmentAurigene Pharmaceutical Services LimitedDr.Ravikumar GopalapillaiScientistBangalore Bioinnovation Centre(BBC)B

40、harat B.DoshiFounder&CEOBioDev Services Private LimitedAmit VernekarFounder DirectorBiosyl Technologies Pvt.Ltd.Devang PandyaAGM-International Business DevelopmentCBCC Global ResearchDr.Mohammad Atif AlamProgramme Lead(Technology Platforms-BD&Projects)Centre for Cellular and Molecular Platforms(C-CA

41、MP)Piyush ChaharDirector&Head-BDChemveda Life Sciences Inc.Manish TandonChief Financial OfficerCuradev PharmaRajesh KumarAssociate Director,Forecasting&AnalyticsDelveInsight Business Research LLPAditya NadimpalliHead BD-Licensing,Strategic Partner-ships,Alliance Management-IndiaDr.Reddys Laboratorie

42、sMayur SangwaiLead,Business DevelopmentDr.Reddys LaboratoriesVenkata S GarimellaVice President Intellectual PropertyDr.Reddys LaboratoriesDr.Himanshu GadgilCEOEnzene Biosciences LimitedINDIA BIOTECHHANDBOOK 202312Dr.Satish NagarajHead-Global Commercial OperationsEnzene Biosciences LimitedEberhard Ra

43、emischHead Business Development CMC&CDMO EuropeEurofins AdvinusDr.Sivasankar BaalasubramanianCEO&Co-FounderImmunitasBio Private LimitedMr.Sundeep BambolkarJt.Managing DirectorIndoco Remedies LtdFerran GarciaVP Biosimilars B2BIntas PharmaceuticalsAnsul SinhaAssistant General Manager-BiosimilarsIntas

44、PharmaceuticalsNilendra SinghBusiness Development Manager(EMEA USA AND APAC)JRF AmericaJay ShethBD Head-US West&CanadaJubilant BiosysDr.Ravichandran SSenior Manager-Business DevelopmentJubilant BiosysKaran Bagaria MDKemwell Biophama Private LimitedNagalakshmi JeedimallaBusiness Development ManagerLa

45、urus LabsAnshuman PatwardhanSenior Vice President,Business Develop-ment,Biotech,Lupin,Inc.Atish MajumdarPresident,Mankind Pharma LtdDr.Ramesh MuthuSVP-Global Business DevelopmentMankind Pharma LtdDr.Mohan ThiruvazhiBusiness ConsultantMestastop Solutions Pvt.Ltd.Saharsh DavuluriVice Chairman&MDNeulan

46、d Laboratories Ltd.Dr.Prabuddha K KunduCo-founder&MDPremas Biotech Pvt LtdDr.Nupur MehrotraCo-founder&COOPremas Biotech Pvt LtdVivek ChandraHead,Global Business DevelopmentPremas Biotech Pvt LtdDr.Manoj KheraCo-Founder 7 DirectorPresude Lifesciences Private LimitedDr.Chirag ShahHead Clinical Operati

47、onsRaptim Research LimitedINDIA BIOTECHHANDBOOK 202313Neha SrivastavaPartnerRemfry&SagarPravin ShuklaDirector Marketing&Business Develop-mentResearchwire Knowledge Solutions Pvt.Ltd.Parag SanchetiCEO,Rubicon Research Pvt LtdSagar OakVP Corporate development&StrategyRubicon Research Pvt LtdDr.Jugnu J

48、ainCEO,Sapien BiosciencesDr.Somnath SakoreTechnical DirectorSeveillar Clinical Supplies Services Pvt LtdSarat PatnaikHead-MarketingStelis Biopharma Pvt.Ltd.Jaydeep IssraniSenior General Manager-Business Development,Sun Pharma Advanced Re-search Company Ltd.(SPARC)Rajesh RanganathanVice President&Hea

49、d,Corporate Development,Sun Pharma Advanced Re-search Company Ltd.(SPARC)Manoj ThombareBusiness Development and LicensingSun Pharmaceutical Industries Ltd.Rajesh SinhaDy General Manager Sun Pharmaceutical Industries Ltd.Anjan ChakrabartiVP&Head of Business Development for North America,Syngene Inter

50、national LimitedDr.Sunit MaitySr.General Manager(Biologics Develop-ment)Syngene International LimitedDr.Sanjoy MahantyVP Head of Business Development-North America,TCG Lifesciences Private LimitedEsmail SamiwalaSr.VP,BiologicsUSV Private LtdMs.Shoba ShenoyGeneral Manager-Biologics ProgramUSV Private

51、 LtdSiddharth ShahDirector-External Innovation-Asia PacificZoetisBinu PhilipSr.General Manager&Head,Business DevelopmentZydus Lifesciences Ltd.Mr.Jijo G.John CEO,Calpine Group to India Delegaton#BIO 2023Dr.D.SudhakaranGeneral ManagerGolden Jubilee Biotech Park for Women SocietyNagalakshmi Jeedimalla

52、Business Development ManagerLaurus LabsAnshuman PatwardhanSenior Vice President,Business Develop-ment,Biotech,Lupin,Inc.Atish MajumdarPresident,Mankind Pharma LtdDr.Ramesh MuthuSVP-Global Business DevelopmentMankind Pharma LtdDr.Mohan ThiruvazhiBusiness ConsultantMestastop Solutions Pvt.Ltd.Saharsh

53、DavuluriVice Chairman&MDNeuland Laboratories Ltd.Dr.Prabuddha K KunduCo-founder&MDPremas Biotech Pvt LtdDr.Nupur MehrotraCo-founder&COOPremas Biotech Pvt LtdVivek ChandraHead,Global Business DevelopmentPremas Biotech Pvt LtdDr.Manoj KheraCo-Founder 7 DirectorPresude Lifesciences Private LimitedDr.Ch

54、irag ShahHead Clinical OperationsRaptim Research LimitedINDIA BIOTECHHANDBOOK 202314Program ScheduleBIO International Convention 2023 June 5-8|Boston,MA,USA India Pavilion Inauguration in Booth 3545 on June 5,2023|12:30 PM by DR.RAJESH S.GOKHALE Secretary,Department of Biotechnology(DBT)Ministry of

55、Science&Technology Government of IndiaScan the QR Code to access India Team ScheduleScan the QR Code to access BIO ScheduleINDIA BIOTECHHANDBOOK An Integrated Drug Discovery CROPLATFORM TECHNOLOGIESDISCOVERY BIOLOGYMEDICINAL CHEMISTRY SERVICES Skanda offers integrated drug discovery solutions Design

56、,synthesis,hit to lead optimization for validateddrug target.We have experienced team of chemist forprocess development/scale up and custom synthesisof drug intermediates,impurities and reference compounds.At Skanda Life Sciences,our Discovery biology divisionprovides comprehensive services to accel

57、erate drugdiscovery and development.We specialize in geneexpression analysis,Western blot studies,cloning,andtransfection focusing on Oncology,CNS,Osteoporosis,Pain and inflammation,metabolic disordes,etc.,Skanda with state of art Bioanalytical facility complementschemistry and Discovery biology tea

58、m for LCMS/MSmethod development,validation as well as quantificationof analytes for permeability/ADME/Pharmacokineticsstudies.BIOANALYTICAL SERVICE CORPORATE OFFICE#12,Sri Shaila Bramara,Nagarabavi,Bangalore-560091,India R&D CENTREPlot No.67-P8,Phase II,Sector-II,KIADB Bidadi Industrial Area,Bidadi,

59、Ramanagar 562109 India Luminescence,Fluorescence,Absorbance FRET,TR-FRET,HTRF,Alpha screen Flow cytometry ELISA,Immunoblotting,IHC,ICC Microscopy PCR/RT-PCR LCMS/MS,GCMS/MS,FTIR,NMR+91-9663399155+91-INDIA BIOTECHHANDBOOK 202316INDIA BIOTECHHANDBOOK 202317INDIA BIOTECHHANDBOOK 202318INDIA TARGETS$150

60、 BILLION BIOECONOMY BY 2025 Indias BioEconomy has crossed an estimated$92 billion by value in the year 2022.The policy makers and industry together have now set an ambitious target of achieving a$150 billion BioEconomy by 2025.INDIA BIOTECHHANDBOOK 202319To achieve a$150 billion BioEconomy in 2025,t

61、he contribution of some sectors needs to nearly double in the next two-three years.This is possible because there are many new green shoots within the biotech segment that are showing signs of great performance.HERES HOW THE$150 BILLION MAGIC WILL HAPPEN BY 2025INDIA BIOTECHHANDBOOK 202320BioPharma

62、sector to grow to nearly$68 billion from$49 billion in 2022(nearly 1.4 times).India made biosimilars are getting accepted in developed markets like the US and we can ex-pect more nations to source cost effective biosimilars in many disease categories as these global quality medical products demonstr

63、ate their efficacy and popularity in foreign countries.The Indian Diagnostics and medical devices market is likely to see a huge jump both in terms of consumption and exports.Covid-19 helped the nation to create the right ecosystem to manufacture,source,and export as well.The modern Diag-nostics Lab

64、s services are spreading beyond big cities and towns.The“RT-PCR tests”done in small places are an indi-cation of the spread of this expertise.Indias BioEconomy from Diagnostics services and medical devices products is expect-ed to touch$30 billion by 2025.Vaccines are expected to generate$17 billion

65、 by 2025 and bio-therapeutics are anticipated to add another$20 billion by 2025.Recombinant and biosimilar products will be big contributors.BioIndustrial is another important sector that has got fillip from the Prime Ministers vision of Atmanirbhar Bharat and India becoming“energy independent”by 20

66、47.The Indian Gov-ernment has approved the amendments to the National Policy on Biofuels and took decisions to increase biofuel production and advance the introduction of ethanol blended petrol with up to 20%blend from April 2023.The amendments include allow-ing more feedstocks for the production of

67、 biofuels.The Biofu-els capacity in India is expected to grow from 5.2 billion liters in 2021 to 10.1 billion liters in 2025(almost doubling).In terms of the economic value,the Biofuel will generate$20 billion BioEconomy by 2025 from$6 billion in 2021(almost tripling).To achieve a$150 billion BioEco

68、nomy is 2022,the contribution of each and some sectors need to nearly double in the next 2-3 years.This is possible because there are many new green shoots within the biotech segment that are showing signs of great performance.HERES HOW THE$150 BILLION MAGIC WILL HAPPEN BY 2025:INDIA BIOTECHHANDBOOK

69、 202321BioAgri,consisting of Bt Cotton,pesticides,marine biotech,and animal biotech has the potential to nearly double its Bio-Economy contribution from$10.5 billion to$20 billion in 2025.The impetus on a circular economy will give the needed push to the sector.The BioServices sector comprising CROs

70、/CDMOs and BioIT segment,is forecast to grow from$6.4 billion to$26.6 billion.The segment will nearly quadruple.Most of the large IT com-panies have dedicated biotech/health care practices.Newer segments like smart proteins and peptide-based mate-rials,contact lens,speech restorers,smart pills,nerve

71、 regen-erators,portable dialysis,prosthetic limbs,new wave of smart telediagnostics will create a nearly$10 billion in BioEconomy.“Alternate foods”or“smart proteins“is the preferred destina-tion for both Innovation and manufacture in the Smart Protein area.There is a very big demand for fermentation

72、 capacities in this area from startups in the US.In the next three years,there is a potential for 10-million-liter fermentation-capac-ities to be set up in India.This will attract an investment of more than$500 million which will generate a revenue of$1 billion every year.These facilities could be l

73、ocated in strategic places which have all the infrastructure for setting these big fermentation faculties.The industry just needs the support from a regulatory and infrastructure point of view to capital-ize on this great emerging opportunity.GRANULARITY-BIOECONOMYSegmentValue in$billion201520162017

74、20182019202020212022Biopharma18.923.824.328.036.038.039.449.8Bioagri9.09.810.311.012.011.110.511.5Bioindustrial1.92.62.94.05.05.110.314.1CRO/BioIT/Research5.35.57.08.09.510.55.49.3Covid Economy0.00.00.00.00.05.514.57.7Total Bioeconomy35.141.644.551.062.570.280.192.3*INDIA BIOTECHHANDBOOK 202322India

75、s BioEconomy has the potential to reach$270-300 billion by year 2030 and account for nearly 3.3-3.5%share of Indias GDP from the 2.8 percent share in 2021.This is possible when the BioPharma sector races to hit the$120-125 billion mark and each of the three segmentsAgriculture in-cluding animal biot

76、ech and marine biotech,Bioindustrial segment and the BioServices segment of Contract research,contract manufacturing,and,BioIT services cross the$60 billion mark.It is possible if the Indian Government continues to take initiatives like it took during Covid and in shaping the Bio-fuels strategy.In t

77、he BioPharma segment,India can leapfrog in the Vaccines and Therapeutics segment.These two together account for nearly 50 percent share of the BioPharma and the Diagnostics labs,medical devices,and services segment estimated to reach$60 billion.The Biofuels segment is likely to contribute nearly$50

78、billion in value,while enzymes will rake in$20 billion.The BioServices segment is likely to touch$50-60 billion or even more.YEAR 2030 FORECASTIndia can leapfrog in the Vaccines and Therapeutics segment.These two together account for nearly 50 percent share of the BioPharma and the Diagnostics labs,

79、medical devices,and services segment estimated to reach$60 billion.INDIA BIOTECHHANDBOOK |AvidInventEmpowering Life Science InnovatorsA specializei fim pioiiiiin compieeeisiie iitellecttal piopeity seiiices foi life scieices aii ceemical scieices.Maximize yoti iiioiatiois piotectioi aii poteitial fi

80、om coiceptioi to commeicializatioi.PatentabilityFTO Prior ArtBio sequences Plant Biotech En?ymesPatent Draftin?Patent Filin?ProsecutionsTech LandscapeCompetitive IntelligenceDr.Puneeta Arora Co-Founder,Registered Patent Agent?Indi?E?.Patent Liaison at DuPont,?years in IPPhD,Biotechnology-CCMB,Postdo

81、c-UNC Chapel?illMr.P.Krishna MohanAdvisor&MentorGlobal Director of Licensing at Dupont(Retd)Ms.Sukriti GoyalCo-Founder,Registered Patent Agent?Indi?E?.Patent Analyst at DuPont,?5 years in IPM.Sc.Biotechnology-IIT Mumbai,Master of Business Law-NLSUI Dr.Becky Abraham Senior Patent AssociateE?.GE,E?.Do

82、w,E?.Clariant,?0 years in IPPhD,Postdoc,Biotechnology,ChemistryDr.Santi Sudha SPatent AssociatePhD,Biochemistry INDIA BIOTECHHANDBOOK 202324PROFILESPROFILESINDIA PAVILION EXHIBITORINDIA PAVILION EXHIBITORINDIA BIOTECHHANDBOOK 202325AIC-CCMB is a premier life-science incubator based in the Pharma Hub

83、 of India,Hyderabad.We offer 20,000 square feet of affordable lab and office space,as well as state-of-the-art equipment,sci-entific services,training,mentoring,and access to a network of professional advisors for entrepreneurs in the life-sciences and healthcare domains.By creating an incubator env

84、ironment that fosters innovation and growth,AIC-CCMB helps these companies succeed and contribute to economic development in the communi-ty.The incubator is promoted by CCMB,a vibrant institute,engaged in molecular,structural,and genomic biology(http:/CCMB.RES.IN).We are focused primarily on lead-st

85、age and product-stage start-ups and support them by bringing in experts in regulatory,clinical,and marketing needs in addition to connecting them to investors.Established with the support of the Atal Innovation Mission(AIM)of the National Institution for Transforming India(NITI Aayog),Gov-ernment of

86、 India at CSIR CCMB,we are dedicated to improving the quality of life for all.With a footprint in medtech,biopharma,animal health,and biodiversity conservation,we believe in indus-try-academia collaboration for One Health,One World.AIC-CCMBwww.aic.ccmb.res.inaicccmb.res.inINDIA BIOTECHHANDBOOK 20232

87、6Biocon Biologics is a unique,fully integrated,global biosimilars company committed to transforming healthcare and transforming lives by enabling affordable access to affordable biologics for mil-lions of patients worldwide.It is leveraging cutting-edge science,innovative tech platforms,global scale

88、 manufacturing capabilities and world class quality systems to lower costs of biological ther-apeutics while improving healthcare outcomes.BBL has acquired the global biosimilars business of its long-standing partner Viatris,which is a historic milestone in its value creation journey.Biocon Biologic

89、s has commercialized eight biosimilars in key emerging markets and advanced markets like U.S.,EU,Australia,Canada,Ja-pan.The Company has a pipeline of 20 biosimilar assets across diabetology,oncology,immunology,and other non-communicable diseases.It has many firsts to its credit in the biosimilars i

90、ndus-try.It has also signed a strategic alliance with Serum Institute Life Sciences for vaccines(subject to certain closing conditions)to ad-dress the inequitable access to lifesaving vaccines.As part of its environmental,social and governance(ESG)commitment,BBL is advancing the health of patients,p

91、eople and the planet to achieve key UN Sustainable Development Goals(SDGs).Biocon Biologics INDIA BIOTECHHANDBOOK 202327Biological E.Limited(BioE),a Hyderabad-based Pharmaceuticals&Biologics Company founded in 1953,is the first private sector biological products company in India and the first pharma

92、ceutical company in Southern India.BioE develops,manufactures and sup-plies vaccines and therapeutics.BioE supplies its vaccines to over 140 countries and its therapeutic products are sold in India and the USA.BioE has regulatory approvals from US FDA/EMEA and other major regulatory agencies across

93、the globe for its vaccines/biolog-ics and injectable facilities.In recent years,BioE has embarked on new initiatives for organiza-tional expansion as a trusted CDMO partner,and is currently serv-ing global clients as the largest and most advanced vaccine and biologics development and manufacturing h

94、ub.BioE offers a fully integrated service at a single site a seamless solution that en-ables partners from clinical scale manufacturing,formulation de-velopment to commercial manufacturing.BioE employs cuttingedge technologies,experts,teams of scientists,to deliver high-quality vaccines and therapeu

95、tics using state-of-the-art facilities.Biological E.LINDIA BIOTECHHANDBOOK 202328Biotechnology Industry Research Assistance Council(BIRAC)is a not-for-profit,Public Sector Enterprise,set up by Department of Biotechnology(DBT),Ministry of Science&Technology,Govern-ment of India.BIRAC/DBT as a central

96、 enabler,nurtures biotech innovation ecosystem in the country to address unmet needs in Healthcare,Agritech,Industrial Biotech and Clean Environment.BIRAC acts at the industry-academia interface and implements its mandate through a wide range of impact initiatives that include providing risk capital

97、 through targeted funding,capacity building,common infrastructure creation,nucleating a network of strategic partnership with public private stakeholders,policy advocacy,data analysis and leads National Missions like Startup India and Make In India for Biotech Sector.Biotechnology Industry Research

98、Assistance Councilwww.birac.nic.inbirac.dbtnic.inINDIA BIOTECHHANDBOOK 202329DSK InnoSciences is a reputable Contract Research Organization for Chemistry with a decade of successful operation offering ser-vices to a wide range of global clients including pharmaceutical,veterinary,cosmetic,fragrance,

99、polymer,electronic,and specialty chemical industries.DSKs operation is housed in a 30,000 sq.ft.building on five acres of land in Greater Bangalore,India.While the Full Time Equivalent(FTE)model focuses on NCE syn-thesis,process development and impurities synthesis,the Fee for Service(FFS)model focu

100、ses on custom synthesis of building blocks,intermediates,reference compounds with delivery ranging from mg to MT.The company differentiates as a solution provider for even the most difficult chemistry problems with a track record of 98%projects leading to successful completion.The company is proud o

101、f their strong commitment to employee welfare,QMS,safety,environmental sustainability,green energy,and social responsibility activities.DSK InnoSciences Breaking SINDIA BIOTECHHANDBOOK 202330IKP Knowledge Park is a research park and incubator in Hyderabad and Bangalore,India,with the mission to adva

102、nce deeptech and co-create solutions for tomorrow in health and plant systems.We build innovation ecosystems.IKP provides land,lab space,technology,incubation,advisory ser-vices,and seed stage funding to innovative companies in biophar-ma,medtech,agri-food,and sustainability.Our footprint spreads ac

103、ross India,with around 1500 innovations supported in 90+cities and towns in the country.This includes innovation projects,start-ups,SMEs,and large companies from India,as well as MNCs from the USA,Germany,Japan,South Korea,and Israel.We are at BIO to discuss opportunities for Tech transfer from our

104、portfolio of some amazing innovations Your presence in our 200-acre campus in Genome Valley,Hyderabad,or at IKP Bangalore Partnership for IKP ONE PRIZE,a set of unique Global Grand Challenges in One Health,Biodiversity and Conservation Cross-border collaborationIKP KNOWLEDGE PARKINDIA BIOTECHHANDBOO

105、K 202331Karnataka Innovation and Technology Society(KITS)functioning under brand“K-tech”administers incentives and concessions to Startups,IT,BT,ESDM and AVGC companies and is also made single point stop for providing all information that facilitates the establishment of above in-dustries in the Sta

106、te.Karnataka has been at the forefront of biotechnology in India and is rightly known as the Biotech Capital of India.The Karnataka Millen-nium Biotechnology Policy of 2001 was the first dedicated biotech-nology promotion and development of Biotech Industry policy in the country.Department has set u

107、p various academic institutes of high repute,innovation hubs and skill development centres across the state to strengthen the biotech ecosystem and has supported 173+Biotech/Agritech/Medtech Startups under Elevate Idea2PoC progam.The bioeconomy of Karnataka is currently valued at USD 24.4 billion co

108、ntributing 33%of the national share and presently hosts about 60%of the bio-tech companies in India and employs about 54%of the countrys total bio-tech workforce.KARNATAKA INNOVATION AND TECHNOLOGY SOCIETYkitsgokkarnataka.gov.inkitsgokkarnataka.gov.inINDIA BIOTECHHANDBOOK 202332Kerala State Industri

109、al Development Corporation(KSIDC)is the pre-mier agency of the Government of Kerala,mandated to for indus-trial and investment promotion in Kerala.Formed in 1961,KSIDCs primary objective was to promote,facilitate and finance large and medium-scale industries and catalyze the development of physical

110、and social infrastructure required for industrial growth in the state.The one-stop-shop for any investment in Kerala,KSIDC offers a comprehensive set of services that an investor needs to set up an enterprise in the State.A nodal agency for foreign and domestic investments in Kerala,KSIDC facilitate

111、s clearances,and approvals,and processes various incentive schemes for starting new busi-ness ventures.KSIDC acts as a spokesman for the State spreading its industrial ethos besides being an interface between the Govern-ment and the Industry.KSIDC team includes a core group of skilled professionals

112、from various fields like Engineering,Management,Finance,and Law.Kerala State Industrial Development Corporationwww.ksidc.orgwww.ksidc.orgINDIA BIOTECHHANDBOOK 202333Pandorum is a biotechnology company working in the fields of Tissue Engineering and Regenerative Medicine,based out of India(Bangalore)

113、and the US(MBC BioLabs,Bay Area).Pandorum uses its proprietary technology platform to develop advanced therapeu-tics for regenerative reprogramming of human tissues.Pandorums technology platform and products are protected by a portfolio of 11 IP families.Pandorums flagship product,Kuragenx-the Liqui

114、d cornea,has demonstrated remarkable vision restoration in New Zealand rabbits suffering from ulcerative corneal blindness with severe inflammation and fibrosis.Kuragenx has been assigned by USFDA to the Office of Tissues and Advanced Therapies,and our First in Human clinical study is planned for 20

115、24 to treat advanced keratitis-a severe indication with unmet medical needs.Pandorum has been supported by a number of Government grants and awards and has raised$15 million so far,from prominent bil-lionaire industrialists and VCs including Binny Bansal,T K Kurien,Sunil Munjal,Indian Angel Network(

116、IAN)and 500 Startups.Pando-rum has tied up with Northwestern University,Feinberg School of Medicine(Chicago,US)as its clinical study partner.Pandorum Tecnologies INDIA BIOTECHHANDBOOK 202334Rx Propellant is Indias leading life science infrastructure platform,building capacities for research and manu

117、facturing.The platform has a portfolio of 6.5 million square feet spanning nine projects in prominent life science clusters in Bengaluru,Hyderabad(Genome Valley)and Mumbai.We offer tenant-configurable Lab Spaces for R&D and built-to-suit Flexi Factories for manufacturing that enable organizations to

118、 establish and expand their operations in India while staying as-set-light.The team brings a unique blend of domain expertise in life science and a deep understanding of the infrastructure needs of the industry.Synergizing with infrastructure,Rx Propellant also provides ecosystem services to ensure

119、tenant success through ini-tiatives such as access to scientific networks,talent-skilling,and support for growth-stage companies.Rx PINDIA BIOTECHHANDBOOK 202335TICEL Biopark Limited,Chennai,Tamil Nadu,India,is a state-of-the-art biotechnology park established in 2004 in Tamil Nadu,India.TICEL Biopa

120、rk is promoted by TIDCO(Tamil Nadu Indus-trial Development Corporation)in technical collaboration with Cornell University,USA.TICEL Biopark supports the biotech ecosystem from the early stages of research to pilot-scale pro-duction by providing laboratory infrastructure and equipment support.Major c

121、ompanies such as Biocon Biologics,Teva Phar-ma,Levim Biotech,and PerkinElmer are located in Ticel Bio Park.TICEL provides laboratory infrastructure that supports the creation of GMP/GLP/Contract Research(CRO)/Contract Manufacturing(CMO)/testing facility.TICEL infrastructure includes utilities such a

122、s an RO water plant,Gas Bank,Vacuum air,Compressed air,Fume hood exhaust with scrubber,HVAC system,Bio waste disposal,and an STP and ETP plant.Other facilities Biotech Core Instrumentation Facility Clean room facility for the production of biopharmaceutical Bio-Incubation CentreTICEL BIOPARK LTDINDI

123、A BIOTECHHANDBOOK 202336Vipragen Biosciences Pvt.Ltd.is a CRO certified by NGCMA for OECD-GLP to carry out safety studies for regulatory submis-sions.The laboratory has been certified by AAALAC,NABL,and DCGI to support drug discovery and development.Vipragen has deep scientific and research knowledg

124、e in areas such as Gen-eral Toxicology,Reproductive Toxicology,Genetic Toxicology,Pharmacology,Analytical Chemistry,Bioanalytical and ADME.Located in the heritage city of Mysore,Vipragen has been serving companies worldwide for over a decade.We serve clients with di-verse research requirements and a

125、ssist them in advancing their product portfolio with reliable data,compliant with global quali-ty standards.The robust platform technology development pro-grammes at Vipragen enable collaborations with global partners to bring innovative solutions to create a safer tomorrow.Vipragen Biosciences Pvt.

126、LINDIA BIOTECHHANDBOOK 202337INDIA BIOTECHHANDBOOK 202338StandOUT Zone 3545-IP13Clonz BiotechEmbioEuprimeRadiant Research Satya Pharma Innovations Skanda Life SciencesSparity,Inc.Stempeutics ResearchRxPropellant3545-IP5BioconBiologics3545-IP650 sq.ft.400 sq.ft.100 sq.ft.200 sq.ft.TICEL3545-IP4Pandor

127、um3545-IP7India Pavilion Exhibitor PositioningINDIA BIOTECHHANDBOOK 202339TICEL3545-IP4Pandorum3545-IP7IKP KnowledgePark3545-IP1KITS,GoK3545-IP2KSIDC3545-IP3BIRAC3545-IP8Vipragen3545-IP9Biological E3545-IP10DSKInnosciences3545-IP11AIC-CCMB3545-IP12India Pavilion Exhibitor Positioning*Images for repr

128、esntation purpose onlyINDIA BIOTECHHANDBOOK 202340India Pavilion 2018INDIA BIOTECHHANDBOOK 202341INDIA BIOTECHHANDBOOK 202342Sl no.OrganizationContact Person1Association of Biotechnology Led Enterprises(ABLE)Dr.Balasubramanya S2Atal Incubation Centre-Centre for Cellular and Molecular Biology(AIC-CCM

129、B)Dr.Ramjee Pallela3Biocon Biologics LimitedMr.Paul V.Thomas4Biological E.LimitedMr.ALN Reddy5Biotechnology Industry Research Assistance Council(BIRAC)Dr.Manish Diwan6DSK InnoSciencesDr.Selva Kumar Natesan7IKP Knowledge ParkMs.Deepanwita Chattopadhyay8Pandorum TechnologiesDr.Tuhin Bhowmick9Rx Propel

130、lantMr.Vishal Goel10TICEL Bio Park LimitedMr.Poongumaran Panneer Selvam11Vipragen BiosciencesDr.Chandrashekaran Siddamadappa12Clonz BiotechDr.Narasimha Rao Nedunri13Embio LimitedMr.Aadya Malladi14EuprimeMr.Akash Murthy15Radiant Research ServicesDr.Ashok Godavarthi16Satya Pharma InnovationsMr.Murthy

131、Chavali(CSN)17Skanda Life SciencesDr.Yogisha.S.18Sparity,Inc.Mr.Srikanth Konda19Stempeutics ResearchMr.BN Manohar20Adam FabriwerkMr.Waman Wagh21Alembic Pharmaceuticals Mr.Abishek Iyer22Algorithmic BiologicsMr.Manoj Gopalkrishnan23Alkem LabsMr.Sandeep Singh24Ami Polymer Pvt LtdMr.Hermes Vora25Atrimed

132、 Plant ScienceMr.Rishi Ganju26Aurigene Oncology LimitedMr.Subir Dubey27Aurigene Pharmaceutical ServicesMr.Akshay Shukla28Bangalore Bioinnovation Centre(BBC)Dr.Ravikumar Gopalapillai29BioDev Services Private LimitedMr.Bharat B.Doshi30Biosyl Technologies Pvt.Ltd.Mr.Amit Vernekar31CBCC Global ResearchM

133、r.Devang Pandya32Centre for Cellular and Molecular Platforms(C-CAMP)Mr.Mohammad Atif Alam33Chemveda Life Sciences Inc.Mr.Piyush Chahar34Curadev PharmaMr.Manish Tandonmanishcuradev.inwww.curadev.inConnect with Team India at BIO 2023Connect with Team India at BIO 2023INDIA BIOTECHHANDBOOK 202343Email

134、IDWebsitegmableindia.org.inwww.ableindia.inramjeeccmb.res.inhttps:/aic.ccmb.res.in/Reddy.ALNsubir_manishcuradev.inwww.curadev.inConnect with Team India at BIO 2023Connect with Team India at BIO 2023INDIA BIOTECHHANDBOOK 20234435DelveInsight Business Research LLPMr.Rajesh Kumar36Dr.Reddys Laboratorie

135、sMr.Aditya Nadimpalli37Enzene Biosciences LimitedDr.Himanshu Gadgil38Eurofins AdvinusMr.Eberhard Raemisch39HiMedia Laboratories Private LimitedMr.Vishal Warkhe40ImmunitasBio Private LimitedMr.Sivasankar Baalasubramanian41Indoco Remedies LtdMr.Sundeep Bambolkar42Intas PharmaceuticalsMr.Ferran Garcia4

136、3Jananom Private LimitedDr.P.M.Murali44Jubilant BiosysMr.Jay Sheth45Kemwell Biopharma Private LimitedMr.Karan Bagaria 46Laurus LabsMs.Nagalakshmi Jeedimalla47Lupin,Inc.Mr.Anshuman Patwardhan48Mankind Pharma LtdMr.Ramesh Muthu49Mestastop Solutions Pvt.Ltd.Dr.Mohan Thiruvazhi50Neuland Laboratories Ltd

137、.Mr.Saharsh Davuluri51Premas Biotech Pvt LtdDr.Prabuddha K Kundu52Presude Lifesciences Private LimitedDr.Manoj Khera53Raptim Research LimitedDr.Chirag Shah54Remfry&SagarMs.Neha Srivastava55Researchwire Knowledge Solutions Pvt.Ltd.Mr.Pravin Shukla56Rubicon Research Pvt LtdMr.Parag Sancheti 57Sapien B

138、iosciencesDr.Jugnu Jain58Seveillar Clinical Supplies Services Pvt LtdDr.Somnath Sakore59Stelis Biopharma Pvt.Ltd.Mr.Sarat Patnaik60Sun Pharma Advanced Research Company(SPARC)Mr.Jaydeep Issrani61Sun Pharmaceutical Industries Ltd.Mr.Manoj Thombare62Syngene International LimitedDr.Sunit Maity63TCG Life

139、sciences Private LimitedDr.Sanjoy Mahanty65USV Private LtdMr.Esmail Samiwala66Zydus Lifesciences Ltd.Mr.Binu Philip67Calpine GroupMr.Jijo G.John68Devsynthesis India Private LimitedMr.Ashutosh Pathak69LEX IP CareMr.Calab Gabriel D.70Pharmadesk Solutions Private limitedDr.Ravindra Bhavsar71P S Davar a

140、nd CompanyMr.Praneed Singh Davar72Golden Jubilee Biotech Park for Women SocietyDr.D.Sudhakarangmbiotechpark.co.inwww.biotechpark.co.inConnect with Team India at BIO 2023Connect with Team India at BIO 2023INDIA BIOTECHHANDBOOK 20234535DelveInsight Business Research LLPMr.Rajesh Kwww.drreddys-https:/

141、with Team India at BIO 2023Connect with Team India at BIO 2023INDIA BIOTECHHANDBOOK 202346Other Indian Companies Other Indian Companies ParticipatingParticipatingAstraZenecaChadha and Chadha AdvocatesCipla LimitedH.K.Acharya&CompanyHiMedia LabsHonour Lab LimitedIP Global ServicesIQVIAJM polymers&gas

142、esJRF AmericaK&S PartnersKrishna&Saurastri AssociatesLakshmi KumaranProRelix Services LLPRCC LabsSpicel Coverage NewsZoetisINDIA BIOTECHHANDBOOK 202347INDIA BIOTECHHANDBOOK 2023481035 EBD Group Pavilion1043Avantor1065 BSP PHARMACEUTICALS S.p.A1073G-CON1084 NorthX Biologics1085 Scorpius BioManuf-actu

143、ring1086Keliomics1135 EBD Group Pavilion1143 Debiopharm International S.A.1149 OK BIO1165 Lonza Pharma&Biotech1172 Wacker Biotech GmbH1178 Goodwin Biotechnology,Inc.1179 Novartis Global Biotech Cooperations1180 Vital Transformation1185 West Pharmaceutical Services1235 Cayman Chemical Company1239 VER

144、AXA Biotech GmbH1243PharmaCircle1245 ACROBiosyste-ms/bioSeedin1249 SciNote-Electronic Lab Notebook1253 Rapid Novor1255 3P Biopharma-ceuticals1257 PSC Biotech1265 Aragen Life Sciences1269 Selkirk Pharma1271 Wheeler Bio,Inc.1273MassBiologics1275 Forge Biologics1277 Sun IP1279Biovian1284 TaiMed Biologi

145、cs1285 Northway Biotech1334Adis1335 German Pavilion1336Cytotheryx1338Vial134 Middlesex Gases1342 Frontage Laboratories,Inc.1343 German Pavilion1346Tigermed135 Predictive Oncology1350 LTS Lohmann Therapy Systems1353 Japan External Trade Organization(JETRO)1354 Rees Scientific1356 CHIRON Recombinant P

146、roteins1358 Paras Biopharma-ceuticals Finland Oy1364 VGXI,Inc.1365 WuXi Biologics1368 Ajinomoto Bio-Pharma Services1372 Philips Pharma Solutions1373Eurogentec1376 Batavia Biosciences1377Anchin1378 Leukocare AG1379 Definitive Healthcare1385 Gene Tools,LLC1387 Kurtzon Lighting139 Avirmax CMC Inc142 I

147、am BIO Studio143 BIO Business Solutions1435 German Pavilion1445 German Pavilion146 BIO Exhibit Sales Office1465 BioTexas Pavilion1472BioHouston1475 NM BIO14781484intoDNA1485 Crown Bioscience1486 APM Health Europe1535 Premier Research1545 German Pavilion1551 Celltrion,Inc.1575 European Pavilion1585 S

148、imcere Pharmaceutical Group1635Henlius1643 PHC Corporation of North America1651Merck1664 Belgium Pavilion1675 European Pavilion1685Selvita1735Pfizer1742 Ascendia Pharmaceuticals1743 SWISS BIOTECH Pavilion1746 Mesa Labs1751 Brazilian Pavilion1765 Avid Bioservices,Inc.1773 Dynamk Capital1785 EMD Seron

149、o,Inc.18351847Biotts1865 WuXi AppTec1873 Ecolab Life Sciences,Purolite1879 Kentucky Pavilion1885 Ami Polymer Pvt Ltd1887UMTR18891935 Pennsylvania Pavilion1946TriNet1947 Health Holland Pavilion1957 Georgia,USA1965Clarivate1969 Almac Group1975 Bayer AG1984 TCG GreenChem,Inc.1985 Rhode Island Commerce

150、Corporation1986 Sikich LLP1988 Eldon James Corporation2035 California Pavilion2043 South Africa2049Quebec2064 Montana BioScience Alliance2065 Italian Trade Agency2068Pillsbury2075Czech2085 Welsh Government2135 City of South San Francisco2141Empatica21432149 Canada Pavilion2175KIT2185 State of Maine2

151、235 New York State Pavilion2240 DIANT Pharma2242Cure2275 China Chamber of International Commerce2285 China Chamber of International Commerce2335 Invest Puerto Rico234Gerresheimer2343 Grand River Aseptic Manufacturing2348 UK Pavilion235 North Carolina Biotechnology Center2375 Nona Biosciences2379 Kal

152、eidoscope Consultants238 Alzheimers Drug Discovery Foundation2385Evaluate2435 Stevanato Group2439EwingCole2443 Nipro PharmaPackaging2447 TALG Law&Clinically Media2449 Inventage Lab Inc2455 Innovation Agency Lithuania246 Patient Advocacy Zone2464 Korea Pavilion2465CAI2471 The Hong Kong Polytechnic Un

153、iversity2474 Iowa Economic Development Authority/Iowa BIO2475 Shanghai YAFO Capital2478 Precision for Medicine2479 MarketScan by Merative2485 Minnesota Department of Employment&Economic Development2534 AES Clean Technology,Inc.2535 BDO Biodefense Group2537ProteoGenix2538 IPTalons,Inc.2542 Barrington

154、 James Limited2543 Holy Stone Healthcare Co.,Ltd.2546 FirstWord Group2547 PharmEng Technology2548 Creative Biolabs2549 ERS Genomics Ltd2551 Guangdong Acxel Micro&Nano Tech Co.,Ltd.2553Salvat2557 GfM-Company for Milling and Micronization INC.2559Scitaris2564Bio-Beat2565 GenScript ProBio USA Inc2566 3

155、DforScience-Visuals for Bio&Health2569 CleanSpace Modular,LLC2570 Compliance Insight Inc2571PharmaLex2572Mednet2574PointClickCare2575 Vendor Managed Gas2577 CarbGeM Inc.2585BIO2634 Biotech Primer2635 Takeda Pharmaceuticals2636 ProMab Biotechn-ologies,Inc.26382642 PolyPeptide Group26432644 PCI Pharma

156、 Services2646 Random42 and Lockwood2649 The Abu Dhabi Pavilion265 Syngene International Limited2650 FRONT PAGE IP2652 Nu Eyne2654Calici2656 Cardinal Health Regulatory Sciences266 MIDI Labs Part of Biolog,Inc.2664Sinopeg2665 Center for Breakthrough Medicines2666 CBCC Global Research2668 BiBo Biopharm

157、a Engineering Co.,Ltd.2673 Momentive Technologies2674 Insilico Medicine2676 Stelis Biopharma2679 Seoul National University R&DB Foundation2684 Quality Chemical Laboratories2685Allucent2686 Wainamics,Inc.2687 Aralez Bio270Primecore272Kneat273Emergent2735 BIO Meet Up Lounge274HealthMatch2743276 Wunder

158、li-ch-Malec Engineering,Inc.2765Australia2777 e-BLOT Life Science(Shanghai)Co.,Ltd.2779 Sterlitech Corporation278 Datwyler Pharma Packaging2784 Huons Global2785 Syntekabio USA Inc.279 Cytovance Biologics Inc2835 Latham BioPharm Group2839 ArcticZymes Technologies284 Surplus Solutions,LLC2843 Axiom Re

159、al-Time Metrics2849 University of Las Vegas285 Barry-Wehmiller Design Group2853Bio-Techne2857IRBM286 TriRadial Solutions2865 Charles River Laboratories2872871 ITR Laboratories Canada Inc2875 Alcami Corporation/Masy BioServices2876 Title21 Health Solutions2878 Recce Pharmaceuticals2879 Zencore Biolog

160、ics288Apprentice.io2881 QPS LLC2884 Avance Clinical2885 Sanyou Biopharma-ceuticals CO.,Ltd.2887 Beijing CorreGene Biotechnology Co.,Ltd289 Clean Biologics2934AlphaSense2935 Biocom California2938Aenova2943GBR2945 Premas Biotech2948 Nitta Gelatin,Inc.2949 Argentina Pavilion2950Phlow2952Mintz2957 City

161、of Vacaville2965 Piramal Pharma Solutions2970 Rise BioServices2971 Contract Pharma2972 Only Orphans Cote LLC2973 Viwit Pharmaceuticals2975 Renaissance Lakewood,LLC2976 CITI Program2977Asymchem2978CorePharma2980BIOSYNTH2981BioPharmaSpec2984 Zhejiang Hengkang Pharmaceutical Co.,Ltd.2985 Groupe Parima2

162、986 Landmark Bio2987Euroapi3035 City of Phoenix Pavilion3042 Solvias USA,LLC3043 South Carolina3057 ImmunoPrecise Antibodies3065 QT9 Software3069 ST Pharm Co.,Ltd.3070Vectura3072 Worcester Polytechnic Institute,Graduate and Professional Studies3074 Navigator Business Solutions3075 INCOG BioPharma Se

163、rvices3076Synplogen3078 Equinox Syringes3079Caregen3080MedPharm3084 Pasco Economic Development Council3085 BIO Lounge3086KACTUS31353145 Trade Estonia3153 LOTTE BIOLOGICS3165 Immuto Scientific3167 Oracle NetSuite3169 uBriGene Biosciences Inc.3173 August Bioservices3174 Lyophilization Technology,Inc.3

164、175 Regis Custom Pharma3176 OFD BioPharma3177 Smart Assays3178 SunBio,Inc.3179Sci.Bio3180 Advaxia Biologics,SRL3181 Phase Clinical Services31853187 HiMedia Labs3189 University of New Hampshire Online3235Mabion3247 Ohio Life Sciences3257 Bionova Scientific LLC3264 Bostal Drug Delivery Co.,Ltd.3265 Sy

165、mbiosis Pharmaceutical Services3266 Chanshow Biotech3268 University of Tsukuba3269FAREVA3272Lumanity3274 Federal Equipment Company3275Dentons3276 Eva Garland Consulting3277Cellvec3278 ApiJect Systems3279ichrogene3281CBRE3284 Pharmsky Research3285 IVIM Technology3286 Corporate Traveler3287 KS-V Pepti

166、de328832893335 Headshot Lounge Sponsored by Amgen3347 Maryland Department of Commerce3355 Oregon Pavilion3364 Environmental Systems Corporation3365 AGC Biologics3366Fermatix3368Triplebar3369 AGC Biologics3370 CMC Technical Solutions3374OPIS3375 U.S.Army Medical Research and Development Command3376 N

167、ACS,Inc.33783380 Brand Institute,Inc.3384NextPharma3385 Biointron Biological Inc3386 Clin-nov Medical Corporation3387 Afton Scientific33883389 Iwata Label USA Inc.3435XtalPi3443 Aurigene Pharmaceutical Services Limited3447 PassPort Technologies,Inc.3449 Gradiant Bioconvergence3453Poland3465Cambrex34

168、693484 Sysmex R&D Center Americas,Inc.3485KOTRA(KFEZ)3486 UI Pharmaceuticals3488 DT&C BIO Group3489Armanino351BIO3535Mexico3545 India Pavilion3546 Genetic-Mi-crodevices Limited3548 Xiamen Amoytop Biotech Co.,LTD.3564 PhenoVista Biosciences3565Curia3566 RBW Consulting356835703575 Federal Laboratory C

169、onsortium3584 Women In Bio3585 PharmaResour-ces(Shanghai)Co.,Ltd.3586 Cobetter North America Corporation3587 NextQure Co.,Ltd.3588 Flagship Lab Services3589 Myra EB Systems3635 A3645 Dallas Regional Chamber365 Samsung Biologics3651 LiveSpo Pharma LTD3653CellionBiomed36553657 Huaqing Tianmu Biotechno

170、logy Co.,Ltd.3659Redwire366536673669ICON3673 AGRILOGICS GROUP3675 ABL Inc.3677 A Georgia,USA36833684 GemPharmatech LLC3685Sampled3686 Xpress Biologics SA3687 Coriell Institute for Medical Research36883689RadaHaim373 IDT Biologika379Abzena384 Matica Biotechnology385Resilience388X-Therma434Citeline443

171、 Trade Commission of Spain-Spain Pavilion(CIF:Q2891001F)451 Massachusetts Pavilion473Germfree475 MIAS Pharma Ltd479BIOVECTRA485Recipharm534 Connecticut Pavilion572 ROUSSELOT BIOMEDICAL574 EquipNet Inc.575BioConnection578 BDO Life Sciences-BioProcess Technology Group579 Prestige Biopharma Limited580

172、Biopeptek Pharmaceuticals LLC585 Kemwell Biopharma Private Ltd.587 SCHOTT Pharma AG&Co.KGaA635MilliporeSigma645 Thailand Pavilion651 New Jersey664Cytiva675 Ocugen,Inc.679 Argonaut Manufacturing Services684685 BIO Process Theater688NewBiologix735AlpalifeBio739Novogene743 Taiwan Pavilion765FUJIFILM774

173、CRB778SEKISUI779 KBI Biopharma,Inc.785 Catalent Biologics834 EBD Group Pavilion835 EBD Group Pavilion837 Signant Health838Intravacc839 BLG LLP-Intrinsik Corp.843 Taiwan Pavilion865 FUJIFILM Diosynth Biotechnologies879 KBI Biopharma,Inc.885 JSR Life Sciences934 EBD Group Pavilion935 EBD Group Pavilio

174、n936 Bird&Bird LLP938 FreeMind Group943 Boehringer Ingelheim Pharmace-uticals,Inc.951 Business France985 Phage Consultants987 BORA PHARMACEUTICAL SERVICES INC.India Pavilion Booth#3545INDIA BIOTECHHANDBOOK 202349Sl noExhibtitorBooth no.1Ami Polymer Pvt Ltd18852Aurigene Pharmaceutical Services Limite

175、d34433CBCC Global Research26664HiMedia Labs31875Kemwell Biopharma Private Ltd.5856Premas Biotech29457Stelis Biopharma26768Syngene International Limited265India ExhibitorsSl noExhibtitorBooth no.1Association of Biotechnology Led Enterprises(ABLE)35452IKP Knowledge Park3545-IP13Karnataka Innovation&Te

176、chnology Society,Govt.of Karnataka3545-IP24Kerala State Industrial Development Corporation(KSIDC)3545-IP35TICEL Bio Park Limited3545-IP46Rx Propellant3545-IP57Biocon Biologics Limited3545-IP68Pandorum Technologies3545-IP79Biotechnology Industry Research Assistance Council(BIRAC)3545-IP810Vipragen Bi

177、osciences Private Limited3545-IP911Biological E.Limited3545-IP1012DSK InnoSciences Private Limited3545-IP1113Atal Incubation Centre-Centre for Cellular and Molecular Biology 3545-IP1214Clonz Biotech Private LimitedStandOUT Zone 3545-IP1315Embio Limited16Euprime17Radiant Research Services Pvt.Ltd.18S

178、atya Pharma Innovations Private Limited19Skanda Life Sciences20Sparity,Inc.21Stempeutics Research Private LimitedIndia Pavilion ExhibitorsINDIA BIOTECHHANDBOOK 202350Association of Biotechnology Led Enterprises-ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector.

179、It was launched in April 2003,after industry leaders felt a need to form an exclusive forum to represent the Indian Biotech-nology Sector.ABLE has over 400 members from all across India representing all verticals of the sector like Agribiotech,Bio-pharma,Industri-al biotech,Bioinformatics,Investment

180、 banks and Venture Capital firms,leading Research and Academic Institutes and Law Firms and Equipment Suppliers.The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology sector in India,through partnering with the Gov-ernment in their biotechnology initiatives to deliver opt

181、imal policies and create a positive regulatory environment,encouraging entre-preneurship and investment in the sector,providing a platform for domestic and overseas companies to explore collaboration and partnerships,forging stronger links between academia and indus-try and showcasing the strengths

182、of the Indian biotech sector.ABLE Council of Presidents,that comprises of all past presidents of the organization,has been set up to provide impetus to the growth of the Biotech business ecosystem to leverage their multi-sectoral expertise.ABLE thus catalyses a symbiotic interface between the industry,the government,academic and research institutes and domestic and international investors.Association of Biotechnology Led Enterprisesinfoableindia.org.inwww.ableindia.inINDIA BIOTECHHANDBOOK 202351INDIA BIOTECHHANDBOOK 202352